President Trump signed an executive order to fast-track the study of using psychedelic drugs to treat Americans – especially ...

President Trump issued an executive order to fast-track psychedelic therapies like ibogaine to treat PTSD and other mental ...

Trump signed an executive order on April 18, 2026, directing the FDA and DEA to fast-track research and approval of ibogaine ...

The FDA’s move follows an executive order from President Donald Trump earlier this month that paved the way for more ...

The FDA did not specify what companies will conduct the research, but two of the companies are studying psilocybin. The third ...

This naturally occurring substance, derived from an African shrub, has been used to treat PTSD, brain trauma, depression, ...

“There’s a need for this because there’s been sort of rumblings in the scientific community that psychedelic medications may ...

(Corrects name of advocacy group to Veterans Exploring Treatment Solutions in paragraph 19) By Jacob Bogage WASHINGTON, April ...

The parents of a decorated veteran from the mission in Afghanistan say that after almost two weeks in an Ottawa jail, their son isn't properly being given the medication he needs to treat his ...

FDA Commissioner Dr. Marty Makary discusses President Donald Trump's executive order on psychedelic drugs for PTSD treatment ...

Utah authorizes a state-funded clinical trial studying psychedelic-assisted therapy for veterans with treatment-resistant ...

Micha Stiebel could not sleep at night. He was short-tempered. Certain sounds would make him jump. “I wasn’t comfortable,” he told The Media Line. “I was always checking people out and looking for ...